Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12569471 | Method of treatment of CNS disorders | 🖼🧊📄§ | 2026-03-10 | 2043-07-17 | 0 | 31 |
| 12569469 | Pharmaceutical composition for oral administration of edaravone and method of administering same | 🖼🧊📄§ | 2026-03-10 | 2045-05-13 | 0 | 31 |
| 12569468 | Use of palovarotene in treatment against HBV virus | 🖼🧊📄§ | 2026-03-10 | 2041-06-01 | 0 | 31 |
| 12569463 | Method for treating diabetes | 🖼🧊📄§ | 2026-03-10 | 2042-09-22 | 0 | 31 |
| 12569459 | Compositions and methods for treating pulmonary edema or lung inflammation | 🖼🧊📄§ | 2026-03-10 | 2041-03-26 | 0 | 31 |
| 12569456 | Methods for the treatment of cysteamine sensitive disorders | 🖼🧊📄§ | 2026-03-10 | 2043-10-13 | 0 | 31 |
| 12569472 | PPARγ agonists for treatment of kidney disease | 🖼🧊📄§ | 2026-03-10 | 2041-04-27 | 0 | 31 |
| 12569455 | Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12569447 | System and method for additive manufacturing using an omnidirectional magnetic movement apparatus | 🖼🧊📄§ | 2026-03-10 | 2044-04-26 | 0 | 31 |
| 12569448 | Membrane-based two component therapeutic gas release system for oral administration | 🖼🧊📄§ | 2026-03-10 | 2040-10-13 | 0 | 31 |
| 12569446 | Enteral sustained-release sugar alcohol additive and preparation method and application thereof | 🖼🧊📄§ | 2026-03-10 | 2045-06-04 | 0 | 31 |
| 12569443 | Gastro-retentive drug delivery system | 🖼🧊📄§ | 2026-03-10 | 2042-06-07 | 0 | 31 |
| 12569440 | Solid formulation of a 1,2,4-oxadiazole derivative | 🖼🧊📄§ | 2026-03-10 | 2040-07-17 | 0 | 31 |
| 12569436 | Self-regulating photo-curable cooling hydrogel and preparation method and application thereof | 🖼🧊📄§ | 2026-03-10 | 2045-09-02 | 0 | 31 |
| 12569437 | Disease-site-specific liposomal formulation | 🖼🧊📄§ | 2026-03-10 | 2043-10-23 | 0 | 31 |
| 12569404 | Methods, systems, and materials for making unit dosage forms | 🖼🧊📄§ | 2026-03-10 | 2043-01-24 | 0 | 31 |
| 12569414 | Sunscreen compositions containing porous metal oxide spheres | 🖼🧊📄§ | 2026-03-10 | 2040-03-12 | 0 | 31 |
| 12569413 | Multifunctional facial patch product | 🖼🧊📄§ | 2026-03-10 | 2043-10-04 | 0 | 31 |
| 12569425 | Aerosol hair care product | 🖼🧊📄§ | 2026-03-10 | 2041-07-15 | 0 | 31 |
| 12569426 | Topical skin preparation composition | 🖼🧊📄§ | 2026-03-10 | 2041-03-22 | 0 | 31 |
| 12569433 | Microemulsion delivery systems for water-based beverages | 🖼🧊📄§ | 2026-03-10 | 2042-02-16 | 0 | 31 |
| 12569429 | Skin penetration enhancer for royal jelly | 🖼🧊📄§ | 2026-03-10 | 2043-10-26 | 0 | 31 |
| 12569049 | Deformable absorbent substrate for a packaging and/or application assembly for a cosmetic product | 🖼🧊📄§ | 2026-03-10 | 2039-06-20 | 0 | 31 |
| 12570707 | Codon-optimised complement factor I | 🖼🧊📄§ | 2026-03-10 | 2039-12-20 | 0 | 31 |
| 12570958 | Single- and multi-chain chimeric antigen receptors | 🖼🧊📄§ | 2026-03-10 | 2038-12-19 | 0 | 31 |
| 12570975 | Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-09-03 | 0 | 31 |
| 12569518 | Cartilage tissue | 🖼🧊📄§ | 2026-03-10 | 2040-02-07 | 0 | 31 |
| 12569567 | Retinoic acid modified lysosome targeting chimera molecule, preparation method and applications thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-16 | 0 | 31 |
| 12569464 | Protein-protein interaction inducing technology | 🖼🧊📄§ | 2026-03-10 | 2041-06-24 | 0 | 31 |
| 12569411 | Preparation and fully compounded stock for use in medical or dental applications, medical or dental product and use and preparation thereof | 🖼🧊📄§ | 2026-03-10 | 2040-07-27 | 0 | 31 |
| 12569423 | Amylose/carotenoids complexation process | 🖼🧊📄§ | 2026-03-10 | 2041-04-01 | 0 | 31 |
| 12571046 | Methods of detecting and treating multiple system atrophy | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12570968 | Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing | 🖼🧊📄§ | 2026-03-10 | 2041-06-24 | 0 | 31 |
| 12570984 | DNA aptamer specifically binding to glutathione and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-02-25 | 0 | 31 |
| 12570711 | Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | 🖼🧊📄§ | 2026-03-10 | 2038-09-27 | 0 | 31 |
| 12570761 | Anti-CEACAM5 antibodies and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-03-25 | 0 | 31 |
| 12570706 | Modified ligand-gated ion channels and methods of use | 🖼🧊📄§ | 2026-03-10 | 2041-09-08 | 0 | 31 |
| 12570729 | Antibody fragment based antifungal conjugate selectively targeting candida | 🖼🧊📄§ | 2026-03-10 | 2041-05-16 | 0 | 31 |
| 12570737 | Liquid preparation containing anti-IL-17 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-12-07 | 0 | 31 |
| 12570766 | Pharmaceutical composition for subcutaneous administration containing human hyaluronidase PH20 variant and drug | 🖼🧊📄§ | 2026-03-10 | 2040-03-24 | 0 | 31 |
| 12570762 | Conjugate or fusion protein for cancer therapy | 🖼🧊📄§ | 2026-03-10 | 2042-09-07 | 0 | 31 |
| 12570763 | Aerosolized mucus-tethering nanobodies to protect against viral and microbial contamination in closed and semi-enclosed spaces | 🖼🧊📄§ | 2026-03-10 | 2041-05-27 | 0 | 31 |
| 12569417 | Compositions and methods for promoting mineralization | 🖼🧊📄§ | 2026-03-10 | 2040-03-13 | 0 | 31 |
| 12569592 | Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof | 🖼🧊📄§ | 2026-03-10 | 2041-11-22 | 0 | 31 |
| 12569562 | Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor | 🖼🧊📄§ | 2026-03-10 | 2042-11-29 | 0 | 31 |
| 12569537 | System and method for the production, formulation and use of conditioned media, cultured cells and the factors included therein | 🖼🧊📄§ | 2026-03-10 | 2040-04-02 | 0 | 31 |
| 12570740 | Treatment for physiological iron overload with an anti-matriptase-2 antibody | 🖼🧊📄§ | 2026-03-10 | 2040-11-27 | 0 | 31 |
| 12570704 | Functionally modified maytansinoids and compositions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-11-05 | 0 | 31 |
| 12570713 | High-affinity TCR for recognizing AFP antigen | 🖼🧊📄§ | 2026-03-10 | 2040-03-06 | 0 | 31 |
| 12570674 | Boron carrying agent for integrated tumor diagnosis and treatment, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-03-01 | 0 | 31 |